Page last updated: 2024-08-25

zoledronic acid and FMR1-Related Primary Ovarian Insufficiency

zoledronic acid has been researched along with FMR1-Related Primary Ovarian Insufficiency in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albert, U; Hadji, P; Kalder, M; Maskow, C; Ziller, M	1
Archer, L; Burstein, HJ; Halabi, S; Hars, V; Hudis, C; Isaacs, C; Kirshner, J; Paskett, E; Schilsky, R; Shapiro, CL; Sikov, W; Weckstein, D; Winer, E	1

Trials

2 trial(s) available for zoledronic acid and FMR1-Related Primary Ovarian Insufficiency

Article	Year
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809. European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:5 Topics: Adult; Antineoplastic Agents; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Fatigue; Female; Fever; Humans; Imidazoles; Infusions, Intravenous; Middle Aged; Pain; Premenopause; Primary Ovarian Insufficiency; Prospective Studies; Zoledronic Acid	2011
CALGB 78909: Phase III trial of intravenous zoledronic acid in the prevention of bone loss in localized breast cancer patients with chemotherapy-induced ovarian failure. Clinical advances in hematology & oncology : H&O, 2005, Volume: 3, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Resorption; Breast Neoplasms; Clinical Protocols; Diphosphonates; Drug Administration Schedule; Female; Humans; Imidazoles; Infusions, Intravenous; Primary Ovarian Insufficiency; Randomized Controlled Trials as Topic; Zoledronic Acid	2005

Article

Year

Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809.

European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:5

Topics: Adult; Antineoplastic Agents; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Fatigue; Female; Fever; Humans; Imidazoles; Infusions, Intravenous; Middle Aged; Pain; Premenopause; Primary Ovarian Insufficiency; Prospective Studies; Zoledronic Acid

2011

CALGB 78909: Phase III trial of intravenous zoledronic acid in the prevention of bone loss in localized breast cancer patients with chemotherapy-induced ovarian failure.

Clinical advances in hematology & oncology : H&O, 2005, Volume: 3, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Resorption; Breast Neoplasms; Clinical Protocols; Diphosphonates; Drug Administration Schedule; Female; Humans; Imidazoles; Infusions, Intravenous; Primary Ovarian Insufficiency; Randomized Controlled Trials as Topic; Zoledronic Acid

2005

Other Studies

1 other study(ies) available for zoledronic acid and FMR1-Related Primary Ovarian Insufficiency

Article	Year
The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer. European journal of cancer (Oxford, England : 1990), 2009, Volume: 45, Issue:18 Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Breast Neoplasms; Calcaneus; Case-Control Studies; Cyclophosphamide; Diphosphonates; Doxorubicin; Female; Hip; Humans; Imidazoles; Lumbar Vertebrae; Middle Aged; Premenopause; Primary Ovarian Insufficiency; Prospective Studies; Statistics, Nonparametric; Time Factors; Ultrasonography; Young Adult; Zoledronic Acid	2009

Article

Year

The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer.

European journal of cancer (Oxford, England : 1990), 2009, Volume: 45, Issue:18

Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Breast Neoplasms; Calcaneus; Case-Control Studies; Cyclophosphamide; Diphosphonates; Doxorubicin; Female; Hip; Humans; Imidazoles; Lumbar Vertebrae; Middle Aged; Premenopause; Primary Ovarian Insufficiency; Prospective Studies; Statistics, Nonparametric; Time Factors; Ultrasonography; Young Adult; Zoledronic Acid

2009